Hepatic IRF8 Expression Suppresses Hepatocellular Carcinoma Progression and Enhances the Response to Anti-PD-1 Therapy

Scientists identified interferon regulatory factor (IRF8) as an important prognostic biomarker in hepatocellular carcinoma patients which predicted the response and sensitivity to anti-PD-1 therapy.